NEKTAR THERAPEUTICS reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
NEKTAR THERAPEUTICS has filed 1,957 SEC EDGAR filings since 14 Feb 1996

SEC filing history

Showing 326-350 of 1,000 matching filings.

Per page
25
Current page
14
8-K File 000-24006

CURRENT REPORT

Filing date
02 May 2022
Reporting date
26 Apr 2022
Next action
Verify source filing
DEFA14A File 000-24006

DEFA14A

Filing date
29 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-24006

DEF 14A

Filing date
29 Apr 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
25 Apr 2022
Reporting date
25 Apr 2022
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
14 Apr 2022
Reporting date
14 Apr 2022
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
14 Mar 2022
Reporting date
14 Mar 2022
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
28 Feb 2022
Reporting date
28 Feb 2022
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Feb 2022
Reporting date
16 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Feb 2022
Reporting date
16 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Feb 2022
Reporting date
16 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Feb 2022
Reporting date
16 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Feb 2022
Reporting date
16 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Feb 2022
Reporting date
16 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45385

SEC SCHEDULE 13G

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45385

PRIMECAP MANAGEMENT CO/CA/

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45385

SC 13G/A filing

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45385

SEC SCHEDULE 13G

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45385

SC 13G/A filing

Filing date
27 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45385

SC 13G/A filing

Filing date
26 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
11 Jan 2022
Reporting date
11 Jan 2022
Next action
Verify source filing
SC 13G/A File 005-45385

SCHEDULE 13G/A

Filing date
10 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2021
Reporting date
16 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2021
Reporting date
16 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2021
Reporting date
16 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .